Veridix, part of Emmes Group ads

Writing preclinical protocols and reports often requires large teams and extensive manual effort—slowing timelines and increasing cost. In this clip, Nageswara Rao Kollu, Senior Director at Apellis Pharmaceuticals, explains how his team used AI-assisted document authoring to reduce manual writing effort while improving speed, consistency, and quality.

Many protocol challenges aren’t mistakes—they’re missed connections. When teams collaborate across functions or organizations without full visibility, important details can fall through the cracks. These gaps often appear later as delays, amendments, or rework. AI authoring co-pilot helps improve alignment early in protocol design—enabling teams to collaborate more effectively and prevent these issues before they surface.

Confidence in protocol design doesn’t come from experience alone. It comes from building protocols with the right structure—integrating inputs from medical, statistics, and operations early in the process. Without that structure, protocols often evolve through manual handoffs between teams, creating inconsistencies and increasing the risk of amendments later in the study. AI-assisted authoring helps teams build structured, consistent protocol content from the start—reducing rework and improving quality across studies

Breakthrough science doesn’t automatically translate into successful clinical trials. As therapies become more targeted and biomarker-driven, designing executable protocols becomes significantly more complex. Without clear translation from scientific insight to operational trial design, promising programs can face delays long before the first patient is enrolled. Structured protocol design helps transform complex scientific insights into executable trial protocols.

Many challenges in clinical trials originate during protocol design. In this clip, a clinical leader discusses how the Veridix Document Authoring Agent can support better early design decisions, helping teams reduce delays and avoid issues later in the trial.

Multiple reports often lead to inconsistent formats and manual edits. In this clip, Nageswara Rao Kollu, Senior Director at Apellis Pharmaceuticals, explains how the Veridix Document Authoring Agent helped his team standardize documentation across reports.